Integrated host/microbe metagenomics enables accurate lower respiratory tract infection diagnosis in critically ill children JCI, 2023
|
Autoantigen profiling reveals a shared post-COVID signature in fully recovered and long COVID patients JCI Insight, 2023
|
Field assessment of BinaxNOW antigen tests as COVID-19 treatment entry point at a community testing site in San Francisco during evolving omicron surges PLOS One, 2023
|
Prolonged silent carriage, genomic virulence potential and transmission between staff and patients characterize a neonatal intensive care unit (NICU) outbreak of methicillin-resistant Staphylococcus aureus (MRSA) Cambridge University Press, 2023
|
Antibodies to repeat-containing antigens in Plasmodium falciparum are exposure-dependent and short-lived in children in natural malaria infections eLife, 2023
|
Dual ankyrinG and subpial autoantibodies in a man with well-controlled HIV infection with steroid-responsive meningoencephalitis: A case report Frontiers, 2023
|
Successful Treatment of Balamuthia mandrillaris Granulomatous Amebic Encephalitis with Nitroxoline Emerging Infectious Diseases, 2023
|
| We are pleased to introduce MITOMI 2.0, a microfluidic platform and analysis pipeline for high-throughput measurement of transcription factor DNA sequence preferences and interaction affinities. Using a panel of 28 S. cerevisiae transcription factors, including 2 that were previously uncharacterized, we demonstrated the ability to comprehensively identify both high- and low-affinity target sequences and directly measure relative binding affinities. We hope that both the extensive data set presented here (including affinity information for each transcription factor binding to 1457 oligonucleotide sequences) and future use of this technique help elucidate the fundamental mechanisms by which transcription factors regulate gene expression. Click here to download the raw Mitomi v2 data from the paper. (18Mb zip archive) |
|